Market darling Oxiana Resources still enjoys the loving support from many a leading brokerage. UBS just turned into a fan, again.
Deutsche Bank doesn’t expect a great deal of impact on the healthcare sector from proposed legislation changes for health insurance. And Ramsay remains its sector favourite.
Junior ASG Group could benefit from Alinta’s aim for extra synergies post the AGL compromise, says Tolhurst Noall.
UBS global has just joined in the rush to upgrade commodity prices and as a result we see the first target price of $100 for Rio. BHP backs up with a solid $38.
It may not happen at next week’s meeting, but economists at the leading brokerages in the country are increasingly convinced interest rates in Australia will rise. Soon.
As usual, ABN Amro’s value discoveries don’t always match opinions of other experts in the market.
Sino Gold’s Jinfeng Mine is well on track for a first pour in the December quarter. In the meantime, ore reserves have increased 38%. Jinfeng has now become a “world class orebody”.
Brace yourself for ongoing discussions whether interest rates should be lifted in Australia or not. Stephen Koukoulas suggests it has become a near fait accompli.
Global investors will have plenty of opportunities to stack up on Chinese shares this year. JP Morgan’s Brian Johnson thinks this will go hand in hand with divestments of Australian bank shares.
UBS has some advice for Sol Trujillo on how to head off the inevitable collapse in fixed-line revenues.